港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

生物医药B类股

363.349

-108.689-23.03%

涨家数：- -

跌家数：33

平家数：1

市盈率：- -

高：471.802

开：471.802

低：361.691

收：472.038

数据加载中...

北京推出32条支持创新医药高质量发展措施

诺华制药(NVS.US)first in class新药在国内申报上市

生物医药股集体大跌相关公司回应关税影响

“一药双价”引危机，悦康药业业绩连降“紧箍咒”难解

【海南海药等投资成立医疗新公司】公开资料显示，近日，海南领拓医疗有限公司成立，法定代表人为杨峥，注册资本为100万元，经营范围包含：第二类医疗器械生产；第三类医疗器械生产；咨询策划服务；企业管理；自有资金投资的资产管理服务；商务代理代办服务等。股权数据显示，该公司由海口高新区国科产业控股有限公司、海南海药共同持股。

港股异动 | 创新药概念股全线重挫美国禁止中国访问NIH核心生物医学数据库机构称创新药暂不受关税影响

迈博药业-B盘中异动快速下挫7.55%报0.490港元

港股异动 | 德琪医药-B(06996)重挫逾30% 塞利尼索海外销售高增机构称关税对医药产业链影响较复杂

贝康医疗-B盘中异动大幅下挫10.37%

康方生物再次转亏，为何市场看好？

远见资本局

心玮医疗-B盘中异动股价大跌8.66%报25.850港元

李氏大药厂盘中异动早盘股价大跌10.00%

加科思-B盘中异动早盘急速跳水18.06%报3.040港元

和铂医药-B股价重挫21.99% 市值跌9.02亿港元

《港股》恒指低开2,119点或9% 科指低开逾11% 医药股跌幅居前

阿斯达克财经

东曜药业-B盘中异动大幅下跌9.05%报1.810港元

云顶新耀-B盘中异动急速下挫10.95%

腾盛博药-B股价重挫14.51% 市值跌1.84亿港元

开拓药业-B盘中异动急速下挫7.58%

再鼎医药盘中异动急速下挫15.10%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1574/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":363.3488,"timestamp":1744013006819,"preClose":472.03796,"halted":0,"volume":364045543,"delay":0,"changeRate":-0.230255,"floatShares":0,"shares":0,"eps":0,"marketStatus":"收市竞价","change":-108.689178,"latestTime":"04-07 16:00:00","open":471.8024,"high":471.8024,"low":361.6905,"amount":5853787636,"amplitude":0.233269,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1744013400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1743989400000,1743998400000],[1744002000000,1744012800000]],"pbRate":3.839353,"peRate":-23.027281,"turnoverRate":0.013959,"increases":0,"decrements":33,"flats":0,"marketCap":207067607584,"floatMarketCap":193539653760},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":471.8024,"amplitude":0.233269,"preClose":472.03796,"low":361.6905,"pbRate":"3.839353","latestPrice":363.3488,"volume":364045543,"delay":0,"open":471.8024,"prevYearClose":331.1933,"prevWeekClose":472.038,"prevMonthClose":455.082,"prevQuarterClose":455.082,"fiveDayClose":459.856,"twentyDayClose":437.197,"sixtyDayClose":320.503,"secType":"PLATE","market":"HK","turnoverRate":0.013959,"peRate":-23.027281,"marketCap":207067607584,"floatMarketCap":193539653760,"timestamp":1744013006819,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":0,"down":33,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525064332","title":"北京推出32条支持创新医药高质量发展措施","url":"https://stock-news.laohu8.com/highlight/detail?id=2525064332","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525064332?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 15:22","pubTimestamp":1744010529,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1576","03347","BK1515","159891","161631","BK1583","BK1574","159938","09939","BK1141","BK1161"],"gpt_icon":0},{"id":"2525694150","title":"诺华制药(NVS.US)first in class新药在国内申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2525694150","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525694150?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 14:50","pubTimestamp":1744008659,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月7日，CDE 官网显示，诺华制药英克司兰钠注射液新适应症上市申请获受理。截至目前，该药已经在包括美国、欧盟以及中国在内的近100个国家获得批准，在欧盟获批4项适应症，在美国获批3项适应症，在中国获批4项适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1274541.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BJJMRZ35.SGD","BK4532","IE0002141913.USD","BK4578","LU0320765489.SGD","BK4585","BK4007","IE00B4R5TH58.HKD","LU0211331839.USD","BK1574","LU0208291251.USD","01477","NVS","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BK1191","BK4588","LU0070302665.USD","IE0009355771.USD"],"gpt_icon":0},{"id":"2525057010","title":"生物医药股集体大跌 相关公司回应关税影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2525057010","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525057010?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 13:17","pubTimestamp":1744003065,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159839","161726","159992","BK1161","BK1574","BK1515","159938","06978","399441","09939"],"gpt_icon":0},{"id":"2525054077","title":"“一药双价”引危机，悦康药业业绩连降“紧箍咒”难解","url":"https://stock-news.laohu8.com/highlight/detail?id=2525054077","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525054077?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 12:16","pubTimestamp":1743999408,"startTime":"0","endTime":"0","summary":"中国医药工业百强企业悦康药业正面临种种挑战。3月中旬，悦康药业发布了2024年财报。近年来，悦康药业业绩已连续三年下滑。核心产品银杏叶提取物注射液深陷舆论漩涡，被指涉嫌“一药双价”。自“一药双价”风波传出，悦康药业股价便持续承压，波动剧烈。2024年12月20日，国家医保局发布《关于对个别药企虚开发票制造“两套价格”问题进行关注的函》，将悦康药业的银杏叶提取物注射液推向风口浪尖。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/254702","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["06978","BK1161","BK1574"],"gpt_icon":0},{"id":"2525051448","title":"【海南海药等投资成立医疗新公司】 公开资料显示，近日，海南领拓医疗有限公司成立，法定代表人为杨峥，注册资本为100万元，经营范围包含：第二类医疗器械生产；第三类医疗器械生产；咨询策划服务；企业管理；自有资金投资的资产管理服务；商务代理代办服务等。股权数据显示，该公司由海口高新区国科产业控股有限公司、海南海药共同持股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2525051448","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525051448?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 11:49","pubTimestamp":1743997746,"startTime":"0","endTime":"0","summary":"公开资料显示，近日，海南领拓医疗有限公司成立，法定代表人为杨峥，注册资本为100万元，经营范围包含：第二类医疗器械生产；第三类医疗器械生产；咨询策划服务；企业管理；自有资金投资的资产管理服务；商务代理代办服务等。股权数据显示，该公司由海口高新区国科产业控股有限公司、海南海药共同持股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/07114949332486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","159891","BK1222","BK0070","09983","09996","09997","159883","BK0146","BK0060","000566","BK1229","BK1258","BK1574","BK1583","BK1542","BK0188","BK1100"],"gpt_icon":0},{"id":"2525055648","title":"港股异动 | 创新药概念股全线重挫 美国禁止中国访问NIH核心生物医学数据库 机构称创新药暂不受关税影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2525055648","media":"智通财经","labels":["policyRegulatory","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525055648?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 11:21","pubTimestamp":1743996103,"startTime":"0","endTime":"0","summary":"消息面上，据一财报道，美国国家卫生研究院 主任办公室网站发布增强NIH受控访问数据安全措施，自上周五起禁止中国、俄罗斯、伊朗等受关注国家机构访问NIH受控访问数据储库存和相关数据。中信建投认为，关税政策冲击下，对医药产业链的影响较为复杂，并且可能仍然存在变数。本次美国对中国加征关税中，药品暂不涉及。当前时点，该行看好暂不受关税影响的创新药行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1274465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1574","01672","LU2488822045.USD","BK1587","159992","02142","00013","LU1969619763.USD","BK1583","BK1589","BK1161","BK1191","06996","BK1588","LU2328871848.SGD","06978","01801"],"gpt_icon":0},{"id":"2525037733","title":"迈博药业-B盘中异动 快速下挫7.55%报0.490港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525037733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525037733?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 10:49","pubTimestamp":1743994161,"startTime":"0","endTime":"0","summary":"2025年04月07日早盘10时49分，迈博药业-B股票出现波动，股价快速跳水7.55%。截至发稿，该股报0.490港元/股，成交量8.2万股，换手率0.00%，振幅7.55%。资金方面，该股资金流入0港元，流出3.64万港元。迈博药业-B股票所在的生物技术行业中，整体跌幅为12.81%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040710492194cdbb19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040710492194cdbb19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1574","BK1161"],"gpt_icon":0},{"id":"2525035642","title":"港股异动 | 德琪医药-B(06996)重挫逾30% 塞利尼索海外销售高增 机构称关税对医药产业链影响较复杂","url":"https://stock-news.laohu8.com/highlight/detail?id=2525035642","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525035642?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 09:50","pubTimestamp":1743990616,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德琪医药-B早盘重挫逾30%，截至发稿，跌29.23%，报2.3港元，成交额856.09万港元。消息面上，德琪医药此前发布年度业绩，该集团取得收入9195万元人民币，同比增加36.62%；研发开支2.59亿元，同比减少36.18%；年内亏损3.19亿元，同比减少45.07%；经调整年内亏损3.05亿元，同比减少42.95%。据悉，2024年塞利尼索销售额同比增长37%至9195万元人民币，其中海外市场增长95%。中信建投认为，关税政策冲击下，对医药产业链的影响较为复杂，并且可能仍然存在变数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1274415.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","159938","06996","BK1515","BK1574","09939","BK1161","BK1583"],"gpt_icon":0},{"id":"2525036371","title":"贝康医疗-B盘中异动 大幅下挫10.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525036371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525036371?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 09:48","pubTimestamp":1743990536,"startTime":"0","endTime":"0","summary":"2025年04月07日早盘09时48分，贝康医疗-B股票出现异动，股价急速跳水10.37%。截至发稿，该股报3.110港元/股，成交量1.45万股，换手率0.02%，振幅0.29%。贝康医疗-B股票所在的生物技术行业中，整体跌幅为10.44%。其相关个股中，中生北控生物科技、中国抗体-B、盛禾生物-B涨幅较大，振幅较大的相关个股有复宏汉霖、华领医药-B、基石药业-B，振幅分别为27.53%、18.14%、17.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040709485694cda361&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040709485694cda361&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1222","BK1597","02170"],"gpt_icon":0},{"id":"2525052120","title":"康方生物再次转亏，为何市场看好？","url":"https://stock-news.laohu8.com/highlight/detail?id=2525052120","media":"远见资本局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525052120?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 09:48","pubTimestamp":1743990513,"startTime":"0","endTime":"0","summary":"从业绩表现来看，康方生物出现了较大的退步，但是市场却对康方生物青睐有加。2023年康方生物授权许可收入高达29.23亿元，公司首次实现归母净利润20.28亿元。而康方生物对2025年的预期较为乐观。值得注意的是，康方生物不仅将眼光放在国内市场，同时也瞄准了国际市场。根据康方生物与Summit的合作协议，康方生物负责药物研发和生产，Summit负责目标市场的临床试验、注册和商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407121258a6b21cbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407121258a6b21cbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","IE00B543WZ88.USD","LU0348784397.USD","IE00BPRC5H50.USD","LU1720050803.USD","09926","LU0417516571.SGD","LU1794554557.SGD","BK1161","LU0348783233.USD","IE00B5MMRT66.SGD","BK1574"],"gpt_icon":0},{"id":"2525503692","title":"心玮医疗-B盘中异动 股价大跌8.66%报25.850港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525503692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525503692?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 09:43","pubTimestamp":1743990231,"startTime":"0","endTime":"0","summary":"2025年04月07日早盘09时43分，心玮医疗-B股票出现波动，股价快速下跌8.66%。截至发稿，该股报25.850港元/股，成交量1150股，换手率0.00%，振幅5.83%。资金方面，该股资金流入1362.5港元，流出3.0085万港元。心玮医疗-B股票所在的医疗设备及用品行业中，整体跌幅为0.54%。其相关个股中，加和国际控股、HKE HOLDINGS、云能国际涨幅较大，振幅较大的相关个股有启明医疗-B、先健科技、复锐医疗科技，振幅分别为14.29%、10.06%、9.60%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407094351a6b1f315&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407094351a6b1f315&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","BK1100","06609"],"gpt_icon":0},{"id":"2525035201","title":"李氏大药厂盘中异动 早盘股价大跌10.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525035201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525035201?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 09:41","pubTimestamp":1743990105,"startTime":"0","endTime":"0","summary":"2025年04月07日早盘09时41分，李氏大药厂股票出现波动，股价快速下挫10.00%。截至发稿，该股报1.260港元/股，成交量3.45万股，换手率0.01%，振幅2.86%。李氏大药厂股票所在的药品行业中，整体跌幅为1.94%。其相关个股中，华控康泰、衍生集团、中生联合涨幅较大，振幅较大的相关个股有德琪医药-B、亿胜生物科技、和黄医药，振幅分别为14.46%、12.60%、10.20%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407094145a45029c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407094145a45029c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","BK1574","BK1587","06622","00950"],"gpt_icon":1},{"id":"2525038749","title":"加科思-B盘中异动 早盘急速跳水18.06%报3.040港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525038749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525038749?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 09:39","pubTimestamp":1743989989,"startTime":"0","endTime":"0","summary":"2025年04月07日早盘09时39分，加科思-B股票出现异动，股价快速下挫18.06%。截至发稿，该股报3.040港元/股，成交量549.33万股，换手率0.70%，振幅9.70%。资金方面，该股资金流入553.689万港元，流出906.143万港元。加科思-B股票所在的生物技术行业中，整体跌幅为8.11%。其相关个股中，中生北控生物科技、正大企业国际、中国抗体-B涨幅较大，振幅较大的相关个股有复宏汉霖、华领医药-B、基石药业-B，振幅分别为27.53%、18.14%、15.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040709394994cd9e81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040709394994cd9e81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01167","BK1161"],"gpt_icon":0},{"id":"2525387050","title":"和铂医药-B股价重挫21.99% 市值跌9.02亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525387050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525387050?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 09:37","pubTimestamp":1743989855,"startTime":"0","endTime":"0","summary":"2025年04月07日早盘09时37分，和铂医药-B股票出现波动，股价急速下跌21.99%。资金方面，该股资金流入1735.15万港元，流出1591.91万港元。最近的财报数据显示，该股实现营业收入2.96亿港元，净利润2,156.43万港元，每股收益数据暂无，毛利2.61亿港元，市盈率213.42倍。和铂医药-B股票所在的生物技术行业中，整体跌幅为8.11%。阿斯利康在华研发正逐步实现全球同步，截至目前已有超过200个研发项目与全球管线同步，主导近20项全球临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407093736aa2c5d6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407093736aa2c5d6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1583","02142"],"gpt_icon":1},{"id":"2525033944","title":"《港股》恒指低开2,119点或9% 科指低开逾11% 医药股跌幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2525033944","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525033944?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 09:37","pubTimestamp":1743989820,"startTime":"0","endTime":"0","summary":"美国总统特朗普对等关税触发美股道指两日内跌逾3,900点，美股期货亚洲早市继续下滑。港股在清明节长周末后复市随外围低开，恒指低开2,119点或9.3%，报20,730点；国指低开763点或9.1%，报7,656点；恒生科技指数低开592点或11.1%，报4,721点。科技股方面，阿里巴巴低开12.6%报108元，腾讯低开11.2%报441.8元，美团低开8.1%报145.1元，小米低开12.4%报40.2元，京东低开10.7%，百度及快手低开12.1%，网易低开9.5%，哔哩哔哩低开15%。车股理想及小鹏低开9.7%及10.6%，吉利、比亚迪及蔚来跌12.5%至14.1%。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180305131110738_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180305131110738_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1431889/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["513600","HSImain","MHImain","HSCEI","09939","HHImain","HSTECH","MCHmain","159938","BK1161","HSI","02833","BK1574","BK1515"],"gpt_icon":1},{"id":"2525036805","title":"东曜药业-B盘中异动 大幅下跌9.05%报1.810港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525036805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525036805?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 09:36","pubTimestamp":1743989801,"startTime":"0","endTime":"0","summary":"2025年04月07日早盘09时36分，东曜药业-B股票出现异动，股价急速跳水9.05%。截至发稿，该股报1.810港元/股，成交量400股，换手率0.00%，振幅0.00%。东曜药业-B股票所在的生物技术行业中，整体跌幅为8.11%。其相关个股中，中生北控生物科技、正大企业国际、中国抗体-B涨幅较大，振幅较大的相关个股有复宏汉霖、基石药业-B、华领医药-B，振幅分别为27.53%、13.31%、12.83%。该公司主要在中国国内市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407093641aa2c5d62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407093641aa2c5d62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01875","BK1574","BK1161"],"gpt_icon":0},{"id":"2525703639","title":"云顶新耀-B盘中异动 急速下挫10.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525703639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525703639?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 09:35","pubTimestamp":1743989740,"startTime":"0","endTime":"0","summary":"2025年04月07日早盘09时35分，云顶新耀-B股票出现波动，股价急速下挫10.95%。截至发稿，该股报52.050港元/股，成交量147.2万股，换手率0.45%，振幅5.05%。机构评级方面，在所有8家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。云顶新耀-B股票所在的生物技术行业中，整体跌幅为8.11%。云顶新耀-B公司简介：云顶新耀有限公司是一家主要从事创新药及疫苗研发、临床开发、制造及商业化的生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407093540aa2c5d5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407093540aa2c5d5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01952","BK1574","BK1161"],"gpt_icon":0},{"id":"2525363270","title":"腾盛博药-B股价重挫14.51% 市值跌1.84亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525363270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525363270?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 09:35","pubTimestamp":1743989740,"startTime":"0","endTime":"0","summary":"2025年04月07日早盘09时35分，腾盛博药-B股票出现波动，股价急速下挫14.51%。截至发稿，该股报1.650港元/股，成交量49.85万股，换手率0.07%，振幅8.29%。资金方面，该股资金流入45.804万港元，流出22.7125万港元。腾盛博药-B股票所在的生物技术行业中，整体跌幅为8.11%。其相关个股中，中生北控生物科技、正大企业国际、中国抗体-B涨幅较大，振幅较大的相关个股有复宏汉霖、华领医药-B、基石药业-B，振幅分别为27.53%、12.83%、12.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407093540a6b1ef0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407093540a6b1ef0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02137","BK1161","BK1587"],"gpt_icon":0},{"id":"2525303644","title":"开拓药业-B盘中异动 急速下挫7.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525303644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525303644?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 09:35","pubTimestamp":1743989740,"startTime":"0","endTime":"0","summary":"2025年04月07日早盘09时35分，开拓药业-B股票出现波动，股价急速下挫7.58%。截至发稿，该股报1.220港元/股，成交量57.2万股，换手率0.13%，振幅7.58%。开拓药业-B股票所在的药品行业中，整体跌幅为1.94%。其相关个股中，华控康泰、衍生集团、中生联合涨幅较大，振幅较大的相关个股有亿胜生物科技、德琪医药-B、联康生物科技集团，振幅分别为12.60%、12.31%、8.70%。该公司在皮科领域有两款核心药物KX-826及GT20029。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040709354094cd9c99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040709354094cd9c99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1574","BK1515","BK1161"],"gpt_icon":0},{"id":"2525038068","title":"再鼎医药盘中异动 急速下挫15.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525038068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525038068?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 09:35","pubTimestamp":1743989740,"startTime":"0","endTime":"0","summary":"2025年04月07日早盘09时35分，再鼎医药股票出现波动，股价急速下挫15.10%。截至发稿，该股报24.450港元/股，成交量176.75万股，换手率0.16%，振幅3.82%。资金方面，该股资金流入2341.59万港元，流出1079.36万港元。再鼎医药股票所在的生物技术行业中，整体跌幅为8.11%。其相关个股中，中生北控生物科技、正大企业国际、中国抗体-B涨幅较大，振幅较大的相关个股有复宏汉霖、华领医药-B、基石药业-B，振幅分别为27.53%、12.83%、12.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040709354097300e06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040709354097300e06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2488822045.USD","BK1588","09688","BK1574"],"gpt_icon":0}],"pageSize":20,"totalPage":35,"pageCount":1,"totalSize":686}]}}